STOCKHOLM, Oct. 24, 2025 /PRNewswire/ — Sobi® (STO: SOBI), a global biopharmaceutical company dedicated to delivering innovative treatments for patients…
BEIJING and GOTHENBURG, Sweden, Oct. 24, 2025 /PRNewswire/ — Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that…